Standard Chemical Pharmaceutical Co., Ltd. Announces 2025 Q4 Earnings Per Share of NT$5.19
Standard Chemical Pharmaceutical Co., Ltd. (Stock Code: 1720) announced its financial report for the fourth quarter of 2025. The company's operating revenue for the quarter was NT$7.023 billion, with a net profit after tax of NT$1.256 billion, and basic earnings per share of NT$5.19. The company belongs to the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 1720
Company Name: Standard Chemical Pharmaceutical Co., Ltd.
Industry: Biotechnology and Medical
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$5.19
Operating Revenue: NT$7.023 billion
Net Profit After Tax: NT$1.256 billion
Company Name: Standard Chemical Pharmaceutical Co., Ltd.
Industry: Biotechnology and Medical
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$5.19
Operating Revenue: NT$7.023 billion
Net Profit After Tax: NT$1.256 billion
FAQ
What was Standard Chemical Pharmaceutical's operating revenue in Q4 2025?
Standard Chemical Pharmaceutical's operating revenue in Q4 2025 was NT$7.023 billion.
What was the net profit after tax for Standard Chemical Pharmaceutical in Q4 2025?
The net profit after tax for Standard Chemical Pharmaceutical in Q4 2025 was NT$1.256 billion.
What were the basic earnings per share for Standard Chemical Pharmaceutical in Q4 2025?
The basic earnings per share for Standard Chemical Pharmaceutical in Q4 2025 were NT$5.19.
What industry does Standard Chemical Pharmaceutical belong to?
Standard Chemical Pharmaceutical belongs to the biotechnology and medical industry.